Xilio Therapeutics XLO Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	196.35M	178.13M	157.41M	139.17M	111.51M	92.36M	77.84M	60.93M
Total Current Assets	181.09M	163.01M	142.31M	124.5M	96.98M	78.43M	64.48M	48.13M
Cash and Equivalents	176.96M	159.41M	139.14M	120.39M	93.27M	75.38M	59.77M	44.7M
Total Non-Current Assets	22.73M	22.56M	22.65M	21.71M	21.78M	20.73M	19.73M	18.61M
Total Liabilities	30.23M	33.91M	31.12M	33.52M	26.71M	24.98M	25.34M	24.1M
Total Current Liabilities	12.23M	17.77M	16.84M	21.12M	16.19M	16.29M	16.93M	15.96M
Total Non-Current Liabilities	26.02M	22.62M	19.06M	15.61M	12.07M	8.69M	8.42M	8.14M
Common Equity	3k	3k	3k	3k	3k	3k	3k	3k
Retained Earnings	-182.24M	-206.85M	-226.64M	-249.11M	-271.75M	-291.11M	-307.86M	-325.51M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	62.72M	36.32M	218.06M	139.17M	60.93M
Total Current Assets	51.1M	20.59M	202.52M	124.5M	48.13M
Cash and Equivalents	48.85M	19.24M	198.05M	120.39M	44.7M
Total Non-Current Assets	-29.52M	-83.29M	185.43M	105.65M	36.83M
Total Liabilities	24.21M	41.6M	32.63M	33.52M	24.1M
Total Current Liabilities	5.21M	22.16M	12.78M	21.12M	15.96M
Total Non-Current Liabilities	28.62M	27.05M	29.6M	15.61M	8.14M
Total Equity	-29.52M	-83.29M	185.43M	105.65M	36.83M
Common Equity	0	1,000	3k	3k	3k
Retained Earnings	-29.87M	-85.09M	-160.89M	-249.11M	-325.51M